Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Verhoeyen

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Blood|September 29, 2021
Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALLKensuke Sasaki, Takuji Yamauchi, Yuichiro Semba, et al.
Frontiers in Immunology|September 12, 2019
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular TherapyRafijul Bari, Markus Granzin, Kam Sze Tsang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2024
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatmentAdrien Krug, Marie Tosolini, Blandine Madji Hounoum, et al.
Frontiers in Immunology|December 17, 2019
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular TherapyRafijul Bari, Markus Granzin, Kam Sze Tsang, et al.
Molecular and Cellular Biology|November 12, 2014
Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell deathMarie Tosolini, Frédéric Pont, Delphine Bétous, et al.
Oncoimmunology|December 3, 2021
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphomaKristin Stirm, Peter Leary, Katrin Bertram, et al.
Human Gene Therapy|October 17, 2018
A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis <i>In Vitro</i>Ekati Drakopoulou, Maria Georgomanoli, Carsten W Lederer, et al.
Plos One|February 16, 2018
Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral geneJanina Gergen, Flora Coulon, Alison Creneguy, et al.
The FEBS Journal|December 19, 2020
Pharmacological preconditioning protects from ischemia/reperfusion-induced apoptosis by modulating Bcl-xL expression through a ROS-dependent mechanismRomain Rozier, Rachel Paul, Blandine Madji Hounoum, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Blood|September 29, 2021
Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALLKensuke Sasaki, Takuji Yamauchi, Yuichiro Semba, et al.
Frontiers in Immunology|September 12, 2019
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular TherapyRafijul Bari, Markus Granzin, Kam Sze Tsang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2024
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatmentAdrien Krug, Marie Tosolini, Blandine Madji Hounoum, et al.
Frontiers in Immunology|December 17, 2019
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular TherapyRafijul Bari, Markus Granzin, Kam Sze Tsang, et al.
Molecular and Cellular Biology|November 12, 2014
Human monocyte recognition of adenosine-based cyclic dinucleotides unveils the A2a Gαs protein-coupled receptor tonic inhibition of mitochondrially induced cell deathMarie Tosolini, Frédéric Pont, Delphine Bétous, et al.
Oncoimmunology|December 3, 2021
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphomaKristin Stirm, Peter Leary, Katrin Bertram, et al.
Human Gene Therapy|October 17, 2018
A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis <i>In Vitro</i>Ekati Drakopoulou, Maria Georgomanoli, Carsten W Lederer, et al.
Plos One|February 16, 2018
Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral geneJanina Gergen, Flora Coulon, Alison Creneguy, et al.
The FEBS Journal|December 19, 2020
Pharmacological preconditioning protects from ischemia/reperfusion-induced apoptosis by modulating Bcl-xL expression through a ROS-dependent mechanismRomain Rozier, Rachel Paul, Blandine Madji Hounoum, et al.
Oncotarget|June 13, 2015
Targeting IRAK1 in T-cell acute lymphoblastic leukemiaCharles Dussiau, Amélie Trinquand, Ludovic Lhermitte, et al.
Pageof 12